BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, Dicarlo L, Feldman AM, Galle E, Ecklund F. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-72. [DOI: 10.1161/circulationaha.106.642892] [Cited by in Crossref: 210] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Varma N, Mittal S, Prillinger JB, Snell J, Dalal N, Piccini JP. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. J Am Heart Assoc 2017;6:e005031. [PMID: 28490521 DOI: 10.1161/JAHA.116.005031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 El Moheb M, Nicolas J, Khamis AM, Iskandarani G, Akl EA, Refaat M. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy. Cochrane Database Syst Rev 2018;12:CD012738. [PMID: 30537022 DOI: 10.1002/14651858.CD012738.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Muser D, Castro SA, Liang JJ, Santangeli P. Identifying Risk and Management of Acute Haemodynamic Decompensation During Catheter Ablation of Ventricular Tachycardia. Arrhythm Electrophysiol Rev 2018;7:282-7. [PMID: 30588317 DOI: 10.15420/aer.2018.36.3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
4 Deo R, Lin F, Vittinghoff E, Tseng ZH, Hulley SB, Shlipak MG. Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease. Hypertension 2008;51:1578-82. [DOI: 10.1161/hypertensionaha.107.103804] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
5 Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol. 2019;56:229-247. [PMID: 31598875 DOI: 10.1007/s10840-019-00623-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Sweeney MO. The Implantable Cardioverter-Defibrillator Minimalist: An Approach to Patient Follow-Up and Management of Implantable Defibrillators. Circulation 2012;126:369-77. [DOI: 10.1161/circulationaha.111.023887] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
7 Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes. 2010;3:159-164. [PMID: 20233980 DOI: 10.1161/circoutcomes.109.875369] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
8 Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY; Document reviewers. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015;17:1169-96. [PMID: 26108808 DOI: 10.1093/europace/euv202] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 14.8] [Reference Citation Analysis]
9 Franczyk-Skóra B, Gluba A, Banach M, Kozłowski D, Małyszko J, Rysz J. Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol 2012;13:162. [PMID: 23206758 DOI: 10.1186/1471-2369-13-162] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
10 Moe SM. Calcium as a cardiovascular toxin in CKD-MBD. Bone 2017;100:94-9. [PMID: 27576942 DOI: 10.1016/j.bone.2016.08.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
11 Hsueh CH, Chen NX, Lin SF, Chen PS, Gattone VH 2nd, Allen MR, Fishbein MC, Moe SM. Pathogenesis of arrhythmias in a model of CKD. J Am Soc Nephrol 2014;25:2812-21. [PMID: 24854269 DOI: 10.1681/ASN.2013121343] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
12 Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK. Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2012;5:762-72. [PMID: 22787010 DOI: 10.1161/CIRCEP.112.971101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Cubbon RM, Gale CP, Kearney LC, Schechter CB, Brooksby WP, Nolan J, Fox KA, Rajwani A, Baig W, Groves D, Barlow P, Fisher AC, Batin PD, Kahn MB, Zaman AG, Shah AM, Byrne JA, Lindsay SJ, Sapsford RJ, Wheatcroft SB, Witte KK, Kearney MT. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail 2011;4:396-403. [PMID: 21562056 DOI: 10.1161/CIRCHEARTFAILURE.110.959882] [Cited by in Crossref: 99] [Cited by in F6Publishing: 48] [Article Influence: 9.9] [Reference Citation Analysis]
14 Straka F, Pirk J, Pinďák M, Skalský I, Vančura V, Čihák R, Marek T, Lupínek P, Schorník D, Mašín J, Zeman M, Škrobáková J, Dorazilová Z, Skibová J. Biventricular Pacing in the Early Postoperative Period After Cardiac Surgery. Physiol Res. [DOI: 10.33549/physiolres.932060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Deng JL, Wu YX, Liu J. Efficacy of implantable cardioconverter defibrillator or cardiac resynchronization therapy compared with combined therapy in survival of patients with heart failure: a meta-analysis. Medicine (Baltimore) 2015;94:e418. [PMID: 25654375 DOI: 10.1097/MD.0000000000000418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Woods B, Hawkins N, Mealing S, Sutton A, Abraham WT, Beshai JF, Klein H, Sculpher M, Plummer CJ, Cowie MR. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart. 2015;101:1800-1806. [PMID: 26269413 DOI: 10.1136/heartjnl-2015-307634] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 12.3] [Reference Citation Analysis]
17 Mozos I. Laboratory markers of ventricular arrhythmia risk in renal failure. Biomed Res Int 2014;2014:509204. [PMID: 24982887 DOI: 10.1155/2014/509204] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
18 Herz ND, Engeda J, Zusterzeel R, Sanders WE, O'Callaghan KM, Strauss DG, Jacobs SB, Selzman KA, Piña IL, Caños DA. Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events. J Womens Health (Larchmt) 2015;24:261-71. [PMID: 25793483 DOI: 10.1089/jwh.2014.4980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
19 Phan D, Narayanan K, Uy-Evanado A, Teodorescu C, Reinier K, Chugh H, Gunson K, Jui J, Chugh SS. T-wave reversal in the augmented unipolar right arm electrocardiographic lead is associated with increased risk of sudden death. J Interv Card Electrophysiol 2016;45:141-7. [PMID: 26628059 DOI: 10.1007/s10840-015-0078-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Kienemund J, Kuck KH, Frerker C. Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block? Arrhythm Electrophysiol Rev 2014;3:190-3. [PMID: 26835090 DOI: 10.15420/aer.2014.3.3.190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Kiuchi MG, Mion D Jr. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? Kidney Res Clin Pract 2016;35:3-9. [PMID: 27069851 DOI: 10.1016/j.krcp.2015.11.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
22 Nauffal V, Zhang Y, Tanawuttiwat T, Blasco-Colmenares E, Rickard J, Marine JE, Butcher B, Norgard S, Dickfeld TM, Ellenbogen KA, Guallar E, Tomaselli GF, Cheng A. Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD. PLoS One 2017;12:e0175205. [PMID: 28388657 DOI: 10.1371/journal.pone.0175205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Palazzuoli A, McCullough PA, Ronco C, Nuti R. Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection. Intern Emerg Med. 2015;10:543-554. [PMID: 25972236 DOI: 10.1007/s11739-015-1246-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
24 Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J 2018;39:2314-25. [PMID: 29522134 DOI: 10.1093/eurheartj/ehy060] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 46.0] [Reference Citation Analysis]
25 Whitman IR, Feldman HI, Deo R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol 2012;23:1929-39. [PMID: 23100219 DOI: 10.1681/ASN.2012010037] [Cited by in Crossref: 72] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
26 Daubert JC, Donal E, Linde C. A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy. Heart Fail Rev 2012;17:767-75. [PMID: 21786181 DOI: 10.1007/s10741-011-9277-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
27 Zheng R, Tian G, Zhang Q, Wu L, Xing Y, Shang H. Clinical Safety and Efficacy of Wenxin Keli-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Systematic Review and Meta-analysis. Front Physiol 2018;9:487. [PMID: 29875671 DOI: 10.3389/fphys.2018.00487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Steiner H, Geist M, Goldenberg I, Suleiman M, Glikson M, Tenenbaum A, Swissa M, Fisman EZ, Golovchiner G, Strasberg B, Barsheshet A; Israeli Working Group of Pacing and EP. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry. Cardiovasc Diabetol 2016;15:160. [PMID: 27905927 DOI: 10.1186/s12933-016-0478-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Nombela-franco L, Mitroi CD, Fernández-lozano I, García-touchard A, Toquero J, Castro-urda V, Fernández-diaz JA, Perez-pereira E, Beltrán-correas P, Segovia J, Werner GS, Javier G, Luis A. Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention: Impact of Chronic Total Coronary Occlusion (VACTO Primary Study). Circ: Arrhythmia and Electrophysiology 2012;5:147-54. [DOI: 10.1161/circep.111.968008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 21] [Article Influence: 11.2] [Reference Citation Analysis]
30 Beca B, Sapp JL, Gardner MJ, Gray C, AbdelWahab A, MacIntyre C, Doucette S, Parkash R. Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy. CJC Open 2019;1:93-9. [PMID: 32159089 DOI: 10.1016/j.cjco.2019.02.002] [Reference Citation Analysis]
31 Doshi RN, Carlson S, Agarwal R, Bharmi R, Adamson PB. Association between Arrhythmia and Pulmonary Artery Pressure in Heart Failure Patients Implanted with a Cardiac Defibrillator and Ambulatory Pulmonary Artery Pressure Sensor. J Innov Card Rhythm Manag 2019;10:3815-21. [PMID: 32477750 DOI: 10.19102/icrm.2019.100903] [Reference Citation Analysis]
32 Xie Y, Li Q, Zhang HF, Huang TC, Yang Y, Lin YQ, Mai JT, Wen ZZ, Yuan WL, Wang JF, Chen YX. Effect of C reactive protein on the sodium-calcium exchanger 1 in cardiomyocytes. Exp Ther Med 2021;22:815. [PMID: 34131438 DOI: 10.3892/etm.2021.10247] [Reference Citation Analysis]
33 Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C, Steffel J, Singh JP, Mela T. Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J 2015;36:2780-9. [PMID: 26264552 DOI: 10.1093/eurheartj/ehv373] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
34 Neuzner J, Gradaus R. [ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection]. Herzschrittmacherther Elektrophysiol 2015;26:75-81. [PMID: 26041117 DOI: 10.1007/s00399-015-0371-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Stewart GC. Mapping the Terrain of Competing Risk Following Primary Prevention Defibrillator Implantation. Circ Heart Fail 2015;8:847-9. [PMID: 26374916 DOI: 10.1161/CIRCHEARTFAILURE.115.002503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Steffel J, Varma N, Robertson M, Singh JP, Bax JJ, Borer JS, Dickstein K, Ford I, Gorcsan J, Gras D, Krum H, Sogaard P, Holzmeister J, Brugada J, Abraham WT, Ruschitzka F. Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial. Circ: Arrhythmia and Electrophysiology 2016;9. [DOI: 10.1161/circep.115.003924] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
37 Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 2010;122:2359-67. [PMID: 21098452 DOI: 10.1161/CIRCULATIONAHA.110.960633] [Cited by in Crossref: 370] [Cited by in F6Publishing: 98] [Article Influence: 33.6] [Reference Citation Analysis]
38 Klein HU. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients. Curr Treat Options Cardiovasc Med 2010;12:431-42. [PMID: 20842565 DOI: 10.1007/s11936-010-0089-2] [Reference Citation Analysis]
39 Shahreyar M, Mupiddi V, Choudhuri I, Sra J, Tajik AJ, Jahangir A. Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death. Expert Rev Cardiovasc Ther 2015;13:897-906. [PMID: 26098816 DOI: 10.1586/14779072.2015.1059276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
40 Benito-González T, Freixa X, Godino C, Taramasso M, Estévez-Loureiro R, Hernandez-Vaquero D, Serrador A, Nombela-Franco L, Grande-Prada D, Cruz-González I, San Antonio R, Galasso M, Gavazzoni M, Garrote C, Portolés-Hernández A, Avanzas P, Fernández-Vázquez F, Pascual I. Ventricular arrhythmias in patients with functional mitral regurgitation and implantable cardiac devices: implications of mitral valve repair with Mitraclip®. Ann Transl Med 2020;8:956. [PMID: 32953756 DOI: 10.21037/atm.2020.02.45] [Reference Citation Analysis]
41 Žižek D, Cvijić M, Ležaić L, Salobir BG, Zupan I. Impact of myocardial viability assessed by myocardial perfusion imaging on ventricular tachyarrhythmias in cardiac resynchronization therapy. J Nucl Cardiol 2013;20:1049-59. [PMID: 24136364 DOI: 10.1007/s12350-013-9795-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Sood MM, Pauly RP, Rigatto C, Komenda P. Left ventricular dysfunction in the haemodialysis population. NDT Plus 2008;1:199-205. [PMID: 25983883 DOI: 10.1093/ndtplus/sfn074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lee DS, Hardy J, Yee R, Healey JS, Birnie D, Simpson CS, Crystal E, Mangat I, Nanthakumar K, Wang X, Krahn AD, Dorian P, Austin PC, Tu JV; Investigators of the Ontario ICD Database. Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators. Circ Heart Fail 2015;8:927-37. [PMID: 26224792 DOI: 10.1161/CIRCHEARTFAILURE.115.002414] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
44 Johnson DM, Antoons G. Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium. Front Physiol 2018;9:1453. [PMID: 30374311 DOI: 10.3389/fphys.2018.01453] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
45 Ruwald MH, Zareba W, Jons C, Zhang C, Ruwald AC, Olshansky B, McNitt S, Bloch Thomsen PE, Shoda M, Merkely B, Moss AJ, Kutyifa V. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial. Circulation 2013;128:694-701. [PMID: 23881862 DOI: 10.1161/CIRCULATIONAHA.113.002472] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
46 Patel KH, Lambiase PD. The subcutaneous ICD-current evidence and challenges. Cardiovasc Diagn Ther 2014;4:449-59. [PMID: 25610802 DOI: 10.3978/j.issn.2223-3652.2014.12.02] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
47 Cao X, Zhou M, Liu H, Chen X, Li X, Jia S. Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2021;12:613922. [PMID: 33692689 DOI: 10.3389/fphar.2021.613922] [Reference Citation Analysis]
48 Bhavnani SP, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J. Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. Ann Noninvasive Electrocardiol 2013;18:379-88. [PMID: 23879278 DOI: 10.1111/anec.12045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
49 Poole JE. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy. Circulation 2014;129:383-94. [PMID: 24446408 DOI: 10.1161/CIRCULATIONAHA.112.000762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
50 Back SH, Kowey PR. Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator. Arrhythm Electrophysiol Rev 2019;8:99-104. [PMID: 31114683 DOI: 10.15420/aer.2018.55.5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Suzuki T, Agarwal SK, Deo R, Sotoodehnia N, Grams ME, Selvin E, Calkins H, Rosamond W, Tomaselli G, Coresh J, Matsushita K. Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2016;180:46-53. [PMID: 27659882 DOI: 10.1016/j.ahj.2016.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
52 Bazoukis G, Letsas KP, Korantzopoulos P, Thomopoulos C, Vlachos K, Georgopoulos S, Karamichalakis N, Saplaouras A, Efremidis M, Sideris A. Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis. J Arrhythm 2017;33:417-23. [PMID: 29021843 DOI: 10.1016/j.joa.2017.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
53 Kiuchi MG, Ho JK, Nolde JM, Gavidia LML, Carnagarin R, Matthews VB, Schlaich MP. Sympathetic Activation in Hypertensive Chronic Kidney Disease - A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death? Front Physiol 2019;10:1546. [PMID: 32009970 DOI: 10.3389/fphys.2019.01546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
54 Francia P, Palano F, Tocci G, Adduci C, Ricotta A, Semprini L, Caprinozzi M, Balla C, Volpe M. Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? ISRN Cardiol 2014;2014:652421. [PMID: 24653841 DOI: 10.1155/2014/652421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
55 Lawson CA, Testani JM, Mamas M, Damman K, Jones PW, Teece L, Kadam UT. Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study. Int J Cardiol 2018;267:120-7. [PMID: 29957251 DOI: 10.1016/j.ijcard.2018.04.090] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
56 Padeletti L, Paoletti Perini A, Gronda E. Cardiac resynchronization therapy: the issue of non-response. Heart Fail Rev 2012;17:97-105. [PMID: 21533977 DOI: 10.1007/s10741-011-9250-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
57 Patel RB, Ng J, Reddy V, Chokshi M, Parikh K, Subacius H, Alsheikh-ali AA, Nguyen T, Link MS, Goldberger JJ, Ilkhanoff L, Kadish AH. Early Repolarization Associated With Ventricular Arrhythmias in Patients With Chronic Coronary Artery Disease. Circ Arrhythm Electrophysiol 2010;3:489-95. [DOI: 10.1161/circep.109.921130] [Cited by in Crossref: 99] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
58 Cevik C, Nugent K, Perez-Verdia A, Fish RD. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review. Clin Cardiol 2010;33:254-60. [PMID: 20513063 DOI: 10.1002/clc.20757] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Poole JE, Gold MR. Who Should Receive the Subcutaneous Implanted Defibrillator?: The Subcutaneous Implantable Cardioverter Defibrillator (ICD) Should Be Considered in all ICD Patients Who Do Not Require Pacing. Circ: Arrhythmia and Electrophysiology 2013;6:1236-45. [DOI: 10.1161/circep.113.000481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 3.9] [Reference Citation Analysis]
60 Narasimha D, Curtis AB. Sex Differences in Utilisation and Response to Implantable Device Therapy. Arrhythm Electrophysiol Rev 2015;4:129-35. [PMID: 26835114 DOI: 10.15420/aer.2015.04.02.129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
61 Höke U, Putter H, Van Der Velde ET, Schalij MJ, Delgado V, Bax JJ, Marsan NA. Left ventricular reverse remodeling, device-related adverse events, and long-term outcome after cardiac resynchronization therapy in the elderly. Circ Cardiovasc Qual Outcomes 2014;7:437-44. [PMID: 24823954 DOI: 10.1161/CIRCOUTCOMES.113.000821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
62 Pun PH. The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. Adv Chronic Kidney Dis 2014;21:480-8. [PMID: 25443573 DOI: 10.1053/j.ackd.2014.06.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
63 Han Z, Chen Z, Lan R, Di W, Li X, Yu H, Ji W, Zhang X, Xu B, Xu W. Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy. PLoS One 2017;12:e0180513. [PMID: 28683134 DOI: 10.1371/journal.pone.0180513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]